No takes yet. Share an insight, caveat, or question.
Highlights the complex end-of-life ethical issues and lack of formal guidelines regarding the deactivation of implantable cardioverter defibrillators in patients with advanced heart failure.
Beattie et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: